Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (51-60 of 420) with videos related to

Pageof 42
Sort By:
Diagnostic Microbiology and Infectious Disease|January 24, 2007
Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)Michael A Pfaller, Helio S Sader, Ronald N Jones
Antimicrobial Agents and Chemotherapy|April 7, 2010
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infectionsDavid J Farrell, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|May 7, 2010
Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centresHelio S Sader, David J Farrell, Ronald N Jones
Antimicrobial Agents and Chemotherapy|January 23, 2014
Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on extended-spectrum-β-lactamase-producing strainsHelio S Sader, Paul R Rhomberg, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United StatesKelley A Gordon, Helio S Sader, Ronald N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2020
Ceftaroline activity against Staphylococcus aureus isolated from patients with infective endocarditis, worldwide (2010-2019)Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniaeRonald N Jones, Thomas R Fritsche, Helio S Sader
Antimicrobial Agents and Chemotherapy|December 25, 2003
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and StreptococciHelio S Sader, David M Johnson, Ronald N Jones
Antimicrobial Agents and Chemotherapy|January 9, 2008
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureusHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 12, 2004
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
Pageof 42

Showing results (51-60 of 420) with videos related to

Sort By:
Pageof 42
Diagnostic Microbiology and Infectious Disease|January 24, 2007
Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005)Michael A Pfaller, Helio S Sader, Ronald N Jones
Antimicrobial Agents and Chemotherapy|April 7, 2010
Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infectionsDavid J Farrell, Helio S Sader, Ronald N Jones
International Journal of Antimicrobial Agents|May 7, 2010
Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centresHelio S Sader, David J Farrell, Ronald N Jones
Antimicrobial Agents and Chemotherapy|January 23, 2014
Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on extended-spectrum-β-lactamase-producing strainsHelio S Sader, Paul R Rhomberg, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|September 12, 2003
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United StatesKelley A Gordon, Helio S Sader, Ronald N Jones
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 18, 2020
Ceftaroline activity against Staphylococcus aureus isolated from patients with infective endocarditis, worldwide (2010-2019)Helio S Sader, Cecilia G Carvalhaes, Rodrigo E Mendes
Diagnostic Microbiology and Infectious Disease|June 21, 2005
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniaeRonald N Jones, Thomas R Fritsche, Helio S Sader
Antimicrobial Agents and Chemotherapy|December 25, 2003
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and StreptococciHelio S Sader, David M Johnson, Ronald N Jones
Antimicrobial Agents and Chemotherapy|January 9, 2008
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureusHelio S Sader, Thomas R Fritsche, Ronald N Jones
Diagnostic Microbiology and Infectious Disease|May 12, 2004
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolatesRonald N Jones, Thomas R Fritsche, Helio S Sader
Pageof 42